Patmi and core patmi grew 16.8% and 27.3% respectively to US$412 million and US$389 million for 1HFY2022. This is attributed to strong recurring income from the growth in the company’s co-investments in funds, associates, and joint ventures.
ESR Group has reported adjusted revenue of US$432 million ($600 million) for 1HFY2022, up 9.4% from the pro-forma 1HFY2021 revenue of US$395 million.
Total ebitda increased by 15.3% from US$577 million in 1HFY2021 to US$665 million in 1HFY2022.
